from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2695/-

LFCtreatmentdescriptionclass of inhibitor

1.351

Amikacinug/mL Amikacintranslation

-0.132

Cap5-10ug/mL Capreomycintranslation

0.512

Rox10-50 ug/mL Roxithromycintranslation

1.272

SM2-5 ug/mL Streptomycintranslation

0.793

Tet5-10 ug/mL Tetracyclinetranslation

0.447

Rif0.2-5ug/mL Rifampicintranscription

-0.272

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.373

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.041

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.092

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.515

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.361

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.003

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.168

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.023

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.636

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.578

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.606

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.620

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.652

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.360

Nigericin50 uM Nigericinrespiration

0.037

TRC10-150 ug/mL Triclosanrespiration

-0.253

TRZ10-25 ug/mL Thioridazinerespiration

-0.870

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.043

menadione6-10 ug/mL Menadionerespiration

0.156

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.059

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.173

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.782

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.725

NRP_1Non-replicating persistence stage 1dosRassociated

0.046

Amp0.2mg/mL AmpicillincellWall

0.541

Cephalexin20-100 ug/mL CephalexincellWall

-0.485

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.055

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.477

EMB10-20 ug/mL EthambutolcellWall

0.686

Eta12-40 ug/mL EthionamidecellWall

1.165

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.092

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.191

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.911

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.171

BZA0.12 mg/mL BenzamidearomaticAmides

-0.133

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.575

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.348

H2O24 mM hydrogen peroxideDNAdamaging

0.219

Levo10 ug/mL LevofloxacinDNAdamaging

-0.420

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.900

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.449

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.093

UVUV-irradiationDNAdamaging

3.577

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.519

Antimycin12.5-50 ug/mL Antimycin A?

-0.591

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.190

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.201

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.155

PA8240.2-2 ug/mL PA-824?

0.682

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.152

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.757

Verapamil50 uM Verapamil?

-0.521

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.022

methoxatin10-20 ug/mL Methoxatin?